0001214659-21-011794.txt : 20211115 0001214659-21-011794.hdr.sgml : 20211115 20211115160121 ACCESSION NUMBER: 0001214659-21-011794 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 EFFECTIVENESS DATE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Octagon Capital Advisors LP CENTRAL INDEX KEY: 0001839435 IRS NUMBER: 843576791 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20958 FILM NUMBER: 211410094 BUSINESS ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-369-2829 MAIL ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001839435 XXXXXXXX 09-30-2021 09-30-2021 false Octagon Capital Advisors LP
654 MADISON AVENUE 16TH FLOOR NEW YORK NY 10065
13F HOLDINGS REPORT 028-20958 N
Justin Hirsch Chief Compliance Officer and Chief Financial Officer 212-369-2829 /s/ Justin Hirsch New York NY 11-15-2021 0 30 406144
INFORMATION TABLE 2 infotable.xml 4D MOLECULAR THERAPEUTICS IN COM 35104E100 22419 831267 SH SOLE 831267 0 0 AMBRX BIOPHARMA INC SPONSORED ADS 02290A102 4725 350000 SH SOLE 350000 0 0 APELLIS PHARMACEUTICALS INC COM 03753U106 52601 1595911 SH SOLE 1595911 0 0 ARCUS BIOSCIENCES INC COM 03969F109 33830 970164 SH SOLE 970164 0 0 ARVINAS INC COM 04335A105 13847 168500 SH SOLE 168500 0 0 AVIDITY BIOSCIENCES INC COM 05370A108 11001 446641 SH SOLE 446641 0 0 BRIDGEBIO PHARMA INC COM 10806X102 26688 569414 SH SOLE 569414 0 0 CARDIFF ONCOLOGY INC COM 14147L108 6545 982753 SH SOLE 982753 0 0 CELLDEX THERAPEUTICS INC NEW COM NEW 15117B202 41108 761398 SH SOLE 761398 0 0 CENTURY THERAPEUTICS INC COM 15673T100 15162 602623 SH SOLE 602623 0 0 CONNECT BIOPHARMA HLDGS LTD ADS 207523101 7795 326143 SH SOLE 326143 0 0 CURIS INC COM NEW 231269200 17968 2294721 SH SOLE 2294721 0 0 CYTEK BIOSCIENCES INC COM 23285D109 10705 500000 SH SOLE 500000 0 0 DESIGN THERAPEUTICS INC COM 25056L103 219 14926 SH SOLE 14926 0 0 DYNE THERAPEUTICS INC COM 26818M108 9478 583649 SH SOLE 583649 0 0 EDGEWISE THERAPEUTICS INC COM 28036F105 830 50000 SH SOLE 50000 0 0 GOSSAMER BIO INC COM 38341P102 19020 1513138 SH SOLE 1513138 0 0 HELIX ACQUISITION CORP COM CL A G4444C102 3948 400000 SH SOLE 400000 0 0 I MAB SPONSORED ADS 44975P103 55416 764461 SH SOLE 764461 0 0 IKENA ONCOLOGY INC COM 45175G108 3471 275000 SH SOLE 275000 0 0 IVERIC BIO INC COM 46583P102 4499 277057 SH SOLE 277057 0 0 JIYA ACQUISITION CORP COM CL A 47760M102 2934 300000 SH SOLE 300000 0 0 MONTE ROSA THERAPEUTICS INC COM 61225M102 3342 150000 SH SOLE 150000 0 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 4204 200000 SH SOLE 200000 0 0 OMEGA THERAPEUTICS INC COMMON STOCK 68217N105 6980 370279 SH SOLE 370279 0 0 PMV PHARMACEUTICALS INC COM 69353Y103 2984 100141 SH SOLE 100141 0 0 PROMETHEUS BIOSCIENCES INC COM 74349U108 4742 200000 SH SOLE 200000 0 0 STOKE THERAPEUTICS INC COM 86150R107 7551 296822 SH SOLE 296822 0 0 TENAX THERAPEUTICS INC COM NEW 88032L209 54 30600 SH SOLE 30600 0 0 VERA THERAPEUTICS INC CL A 92337R101 12078 696126 SH SOLE 696126 0 0